| MORPHOSYS AG O.N. | 39.2100 / -1.13% |
| Date/Time | 10/15 / 17:48 |
| Chg. / Chg.(%) | -0.4500 / -1.13% |
| Bid | - |
| Ask | - |
| Open | 40.1900 |
| Previous Close | 39.6600 |
| High | 40.1900 |
| Low | 39.0000 |
| Volume [EUR] | 39,900.6500 |
| Volume [Units] | 1,015 |
| Price fixings | 9 |
| ISIN | DE0006632003 |
| Security | MOR |
| Exchange | Frankfurt |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 39.240 |  |
|
| Xetra | 39.220 |  |
173,380 |
| TradeGate | 39.460 | |
39,846 |
| Cboe Europe .. | 39.25 | |
19,330 |
| London Inter.. | 39.60 | |
17,207 |
| Turquoise | 39.26 | |
8,005 |
| gettex | 39.400 | |
5,109 |
| Stuttgart | 39.290 | |
4,730 |
| Frankfurt | 39.2100 | |
1,015 |
| Quotrix | 39.4400 | |
467 |
| Berlin | 40.190 |  |
13 |
| Vienna Globa.. | 39.26 | |
0 |
| Hannover | 39.960 | |
0 |
| München | 40.010 | |
0 |
| Hamburg | 39.960 | |
0 |
| Düsseldorf | 39.220 | |
0 |
| Cboe Europe .. | 39.41 | 336 | |
| Nasdaq Other.. | 45.9375 | 410 | |
| Cboe Europe .. | 39.65 | 704 | |
| EUREX | Options | ||
News
- Royalty Pharma Reports Second Quarter 2021 Results
08/11/2021 / 13:00 - GlobeNewswire - CONSTELLATION ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of CNST and Encourages Investors to Contact the Firm
06/03/2021 / 20:27 - GlobeNewswire - Royalty Pharma Announces $2.025 Billion Strategic Funding Partnership With MorphoSys
06/02/2021 / 13:40 - GlobeNewswire - I-Mab and MorphoSys Announce First Patient Dosed in Phase 3 Clinical Trial of TJ202/MOR202 in r/r Multiple Myeloma in Mainland China
04/27/2020 / 22:01 - GlobeNewswire - MOR106 clinical development in atopic dermatitis stopped for futility
10/28/2019 / 21:45 - GlobeNewswire
Real-time